KRYS – Krystal Biotech, Inc.
Krystal Biotech, Inc.KRYS
$135.80Name : Krystal Biotech, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $3,924,443,648.00
EPSttm : 4.17
Krystal Biotech, Inc.
$135.80
2.40%$3.18Float Short %
10.48
Margin Of Safety %
56
Put/Call OI Ratio
0.99
EPS Next Q Diff
0.21
EPS Last/This Y
2.76
EPS This/Next Y
5.08
Price
132.62
Target Price
205.2
Analyst Recom
1.18
Performance Q
-25.88
Relative Volume
0.69
Beta
0.66
Ticker: KRYS
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-05-07 | KRYS | 136.75 | 0.77 | 0.13 | 6904 |
| 2025-05-08 | KRYS | 137.17 | 0.57 | 0.26 | 6262 |
| 2025-05-09 | KRYS | 132.03 | 0.54 | 0.45 | 6355 |
| 2025-05-12 | KRYS | 139.44 | 0.49 | 1.91 | 7953 |
| 2025-05-13 | KRYS | 134.63 | 0.48 | 2.51 | 8199 |
| 2025-05-14 | KRYS | 131.34 | 0.77 | 0.03 | 9794 |
| 2025-05-15 | KRYS | 130.32 | 0.68 | 0.08 | 10578 |
| 2025-05-16 | KRYS | 131.6 | 0.65 | 4.10 | 11004 |
| 2025-05-19 | KRYS | 132.32 | 1.07 | 2.50 | 6546 |
| 2025-05-20 | KRYS | 131.61 | 1.05 | 0.00 | 6632 |
| 2025-05-21 | KRYS | 126.53 | 1.04 | 2.05 | 6665 |
| 2025-05-22 | KRYS | 125.25 | 1.09 | 0.03 | 6859 |
| 2025-05-23 | KRYS | 126.05 | 1.08 | 0.14 | 6884 |
| 2025-05-27 | KRYS | 127.45 | 0.87 | 0.08 | 8036 |
| 2025-05-28 | KRYS | 123.51 | 0.87 | 7.33 | 8064 |
| 2025-05-29 | KRYS | 125.52 | 0.88 | 0.75 | 8084 |
| 2025-05-30 | KRYS | 125.95 | 0.88 | 0.01 | 8083 |
| 2025-06-02 | KRYS | 125.35 | 0.79 | 1.33 | 8595 |
| 2025-06-03 | KRYS | 131.04 | 0.79 | 0.96 | 8624 |
| 2025-06-04 | KRYS | 132.12 | 0.80 | 5.35 | 8819 |
| 2025-06-05 | KRYS | 132.82 | 0.99 | 0.99 | 9863 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-05-07 | KRYS | 136.80 | 231.2 | 104.4 | 7.65 |
| 2025-05-08 | KRYS | 137.27 | 98.0 | 79.7 | 6.69 |
| 2025-05-09 | KRYS | 132.18 | 35.2 | 69.6 | 5.88 |
| 2025-05-12 | KRYS | 139.43 | 35.2 | 92.6 | 5.88 |
| 2025-05-13 | KRYS | 134.53 | 35.2 | 70.0 | 5.88 |
| 2025-05-14 | KRYS | 131.43 | 35.2 | 73.0 | 5.88 |
| 2025-05-15 | KRYS | 130.41 | 35.2 | 76.9 | 5.88 |
| 2025-05-16 | KRYS | 130.55 | 35.2 | 79.3 | 5.88 |
| 2025-05-19 | KRYS | 132.29 | 35.2 | 82.1 | 5.88 |
| 2025-05-20 | KRYS | 131.54 | 35.2 | 77.4 | 5.88 |
| 2025-05-21 | KRYS | 126.63 | 35.2 | 69.4 | 5.88 |
| 2025-05-22 | KRYS | 125.23 | 35.2 | 75.9 | 5.88 |
| 2025-05-23 | KRYS | 125.11 | 35.2 | 78.4 | 5.88 |
| 2025-05-27 | KRYS | 126.45 | 35.2 | 81.7 | 5.88 |
| 2025-05-28 | KRYS | 123.44 | 35.2 | 72.8 | 5.88 |
| 2025-05-29 | KRYS | 125.48 | 35.2 | 83.2 | 5.88 |
| 2025-05-30 | KRYS | 125.96 | 35.2 | 79.5 | 5.88 |
| 2025-06-02 | KRYS | 125.22 | 35.2 | 77.4 | 5.88 |
| 2025-06-03 | KRYS | 130.91 | 35.2 | 90.1 | 5.88 |
| 2025-06-04 | KRYS | 132.11 | 35.2 | 81.2 | 5.88 |
| 2025-06-05 | KRYS | 132.62 | 35.2 | 79.9 | 5.88 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-05-07 | KRYS | -4.56 | -0.37 | 9.79 |
| 2025-05-08 | KRYS | -4.56 | -0.37 | 9.79 |
| 2025-05-09 | KRYS | -4.56 | -0.37 | 9.79 |
| 2025-05-12 | KRYS | -4.56 | -2.14 | 9.58 |
| 2025-05-13 | KRYS | -4.57 | -2.14 | 9.58 |
| 2025-05-14 | KRYS | -4.57 | -2.14 | 9.58 |
| 2025-05-15 | KRYS | -4.57 | -2.14 | 9.58 |
| 2025-05-16 | KRYS | -4.57 | -2.14 | 9.58 |
| 2025-05-19 | KRYS | -4.57 | -1.85 | 9.54 |
| 2025-05-20 | KRYS | -4.68 | -1.85 | 9.54 |
| 2025-05-21 | KRYS | -4.68 | -1.85 | 9.54 |
| 2025-05-22 | KRYS | -4.68 | -1.85 | 9.54 |
| 2025-05-23 | KRYS | -4.68 | -1.85 | 9.54 |
| 2025-05-27 | KRYS | -4.68 | -2.05 | 9.54 |
| 2025-05-28 | KRYS | -4.68 | -2.05 | 10.48 |
| 2025-05-29 | KRYS | -4.68 | -2.05 | 10.48 |
| 2025-05-30 | KRYS | -4.68 | -2.05 | 10.48 |
| 2025-06-02 | KRYS | -4.68 | -1.27 | 10.48 |
| 2025-06-03 | KRYS | -4.68 | -1.27 | 10.48 |
| 2025-06-04 | KRYS | -4.68 | -1.27 | 10.48 |
| 2025-06-05 | KRYS | -4.68 | -1.27 | 10.48 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.2
Avg. EPS Est. Current Quarter
1.26
Avg. EPS Est. Next Quarter
1.41
Insider Transactions
-4.68
Institutional Transactions
-1.27
Beta
0.66
Average Sales Estimate Current Quarter
95
Average Sales Estimate Next Quarter
105
Fair Value
206.74
Quality Score
87
Growth Score
44
Sentiment Score
79
Actual DrawDown %
39.5
Max Drawdown 5-Year %
-53.4
Target Price
205.2
P/E
31.94
Forward P/E
15.21
PEG
0.52
P/S
11.49
P/B
3.89
P/Free Cash Flow
29.64
EPS
4.15
Average EPS Est. Cur. Y
5.88
EPS Next Y. (Est.)
10.95
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
37.18
Relative Volume
0.69
Return on Equity vs Sector %
-11.4
Return on Equity vs Industry %
6.4
EPS 1 7Days Diff
EPS 1 30Days Diff
-1.7
EBIT Estimation
79.9
Krystal Biotech, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 275
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
stock quote shares KRYS – Krystal Biotech, Inc. Stock Price stock today
news today KRYS – Krystal Biotech, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch KRYS – Krystal Biotech, Inc. yahoo finance google finance
stock history KRYS – Krystal Biotech, Inc. invest stock market
stock prices KRYS premarket after hours
ticker KRYS fair value insiders trading